Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing Magnetic Resonance Imaging (MRI)-Targeted Biopsy and Extended Transperineal Systematic Biopsy for Detection of Clinically Significant Prostate Cancer: the SMART Trial

NCT04685928 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04685928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04685928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing Magnetic Resonance Imaging (MRI)-Targeted Biopsy and Extended Transperineal Systematic Biopsy for Detection of Clinically Significant Prostate Cancer: the SMART Trial
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2021
Completion date
September 24, 2024
Enrollment
403 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer